Speaker

Jeremiah Bearss

Vice President - Clinical Development, Biolexis Therapeutics

Jeremiah Bearss, Vice President - Clinical Development at Biolexis Therapeutics, is speaking at 3rd Obesity & Weight Loss Drug Development Summit West (San Diego, United States of America, 9–10 Dec 2026) in the session “Advancing a New Approach to Obesity Treatment Through Differentiated Oral GLP-1 Biology, Favorable Tolerability, & Muscle-Preserving Combination Potential”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

3rd Obesity & Weight Loss Drug Development Summit West
9–10 Dec 2026San Diego, United States of America
- SpeakerAdvancing a New Approach to Obesity Treatment Through Differentiated Oral GLP-1 Biology, Favorable Tolerability, & Muscle-Preserving Combination Potential

More speakers at 3rd Obesity & Weight Loss Drug Development Summit West

Mini Balakrishnan
Vice President, Biology, Biomea Fusion
Ashok Bhandari
Executive Vice President & Chief Discovery Officer, Protagonist Therapeutics
Patrick Griffin
Founder & CEO, Incregen Therapeutics
Charles Harris
Associate Vice President, Eli Lilly & Co.
Hans Keirstead
Chairman, Immunis
Greg Luerman
Vice President, Research & Partnerships, Curi Bio

See all 11 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Jeremiah Bearss, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].